Your browser doesn't support javascript.
loading
CD19-negative relapse in adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia following treatment with blinatumomab-a post hoc analysis.
Horst, Heinz-August; Zugmaier, Gerhard; Martinelli, Giovanni; Mergen, Noemi; Velasco, Kelly; Zaman, Faraz; Kantarjian, Hagop.
Affiliation
  • Horst HA; Department of Internal Medicine II, University Hospital of Schleswig-Holstein, Kiel, Germany.
  • Zugmaier G; Amgen Research (Munich) GmbH, Munich, Germany.
  • Martinelli G; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Mergen N; Amgen Research (Munich) GmbH, Munich, Germany.
  • Velasco K; Amgen Inc., Thousand Oaks, California, USA.
  • Zaman F; Amgen Inc., Thousand Oaks, California, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 98(8): E222-E225, 2023 08.
Article in En | MEDLINE | ID: mdl-37345570

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Limits: Adult / Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Limits: Adult / Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: Germany